These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34102997)

  • 1. Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
    Shibata M; Hoshino R; Shimizu C; Sato M; Furuta N; Ikeda Y
    BMC Neurol; 2021 Jun; 21(1):217. PubMed ID: 34102997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinus node dysfunction: an adverse effect of lacosamide.
    Chinnasami S; Rathore C; Duncan JS
    Epilepsia; 2013 Jun; 54(6):e90-3. PubMed ID: 23360388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
    Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
    Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
    Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
    Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
    Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
    Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures.
    Degiorgio CM
    Epilepsy Behav; 2010 Jul; 18(3):322-4. PubMed ID: 20570216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lacosamide associated with high-degree block in a patient with trigeminal neuralgia].
    Marin-Gracia M; Cantero-Lozano D; Garces-Anton E; Lopez-Bravo A; Garrido-Fernandez A; Navarro-Perez MP; Santos-Lasaosa S; Garces-Redondo M
    Rev Neurol; 2018 Mar; 66(6):189-192. PubMed ID: 29537058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
    Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ
    Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forced normalization of Lennox-Gastaut syndrome using lacosamide: A case report.
    Ono-Takiguchi Y; Muramatsu K; Koshu K; Yamagata T
    Brain Dev; 2021 Oct; 43(9):963-966. PubMed ID: 34049745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience combined with therapeutic drug monitoring of lacosamide.
    Svendsen T; Brodtkorb E; Baftiu A; Lossius MI; Nakken KO; Johannessen SI; Johannessen Landmark C
    Acta Neurol Scand; 2020 Apr; 141(4):279-286. PubMed ID: 31853958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy.
    Izzi F; Placidi F; Liguori C; Posca I; Lauretti B; Diomedi M; Pisani A; Mercuri NB; Rocchi C
    J Neurol Sci; 2020 Nov; 418():117095. PubMed ID: 32841918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
    Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
    Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
    Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
    Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes following exposure to lacosamide monotherapy during pregnancy and breastfeeding - a prospective case series.
    Bosak M; Dziedzic R; Matwiej K; Słowik A
    Neurol Neurochir Pol; 2024; 58(2):203-206. PubMed ID: 38305480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy.
    Nizam A; Mylavarapu K; Thomas D; Briskin K; Wu B; Saluja D; Wong S
    Epilepsia; 2011 Oct; 52(10):e153-5. PubMed ID: 21801173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioembolic acute cerebral micro-infarcts in the context of atrial fibrillation after low-dose intravenous infusion of lacosamide.
    Corbellini ÁB; Torre PP; Hristova VN; Sanz BZ; García ACC; Jorge FR; García JLC; Díaz PP; Catevilla FJB
    Epileptic Disord; 2020 Feb; 22(1):83-89. PubMed ID: 32043469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy.
    Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E
    Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of treatment with lacosamide in children: Postmarketing experience from the Middle East.
    Hmaimess G; Sabbagh S; Dirani M; Hotait M; Beydoun AA; Nasreddine W
    Seizure; 2020 Jul; 79():75-79. PubMed ID: 32422546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.